NCT05360745 2026-02-11
FOODPANC
Fundacion para la Excelencia y la Calidad de la Oncologia
Phase NA Withdrawn
Clinical Trials
103 trialsNCT06626256 2025-12-24
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
City of Hope Medical Center
Phase 1 Withdrawn
NCT05737615 2025-09-04
PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9
Memorial Sloan Kettering Cancer Center
Phase 1 Withdrawn
NCT05634525 2025-07-25
Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT06498518 2025-07-11
PRIMUS006
University of Glasgow
Phase 2 Withdrawn
NCT02414100 2025-05-02
Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy
Thomas Jefferson University
Withdrawn
NCT03541486 2025-03-10
XACT-PANC-2
University of Iowa
Phase 2 Withdrawn
NCT06206876 2025-01-17
FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute
Phase 1 Withdrawn
NCT05610826 2024-10-26
Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver
University of Chicago
Phase 1/2 Withdrawn
NCT02745197 2024-09-19
A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer
University of Alberta
Phase 2 Withdrawn
NCT06054308 2024-08-21
CART
Chinese University of Hong Kong
Phase NA Withdrawn
NCT06110598 2024-08-15
CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)
Case Comprehensive Cancer Center
Phase 2 Withdrawn
NCT06398587 2024-07-19
Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer Institute
Phase 2 Withdrawn
NCT04833959 2024-06-21
Pilot Study of 89-Zr Panitumumab in Pancreas Cancer
Stanford University
Phase 1 Withdrawn
NCT05471401 2024-06-13
GI Organ Tracking Via Balloon Applicators
Washington University School of Medicine
Phase NA Withdrawn
NCT01913275 2024-01-31
Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy
All India Institute of Medical Sciences
Phase NA Withdrawn
NCT05238831 2024-01-23
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT04870034 2023-12-22
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT03245658 2023-12-18
The Effect of Cannabis in Pancreatic Cancer
University of Copenhagen
Phase 2 Withdrawn
NCT06017323 2023-10-25
ProglumidePanc
Georgetown University
Phase 1 Withdrawn
NCT05379907 2023-09-06
Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
Inova Health Care Services
Withdrawn
NCT05216120 2023-07-03
Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas
HonorHealth Research Institute
Phase 2 Withdrawn
NCT02515513 2023-06-28
The Role of Muscle Cachexia in Pancreatic Cancer
University of Florida
Phase NA Withdrawn
NCT05431582 2023-06-15
Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT05251038 2023-05-11
Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer
Hoosier Cancer Research Network
Phase 1/2 Withdrawn
NCT04799431 2023-05-09
Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Withdrawn
NCT04852367 2023-04-12
PanDox
University of Oxford
Phase 1 Withdrawn
NCT04420130 2022-10-04
A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）
Harbin Medical University
Phase NA Withdrawn
NCT03199144 2022-06-23
CKPancreas
Centre Francois Baclesse, Luxembourg
Phase 2 Withdrawn
NCT01371240 2022-06-16
Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
University Hospitals Cleveland Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT05212025 2022-06-14
Adavosertib and Gemcitabine in Advanced Pancreatic
Dana-Farber Cancer Institute
Phase 2 Withdrawn
NCT04270929 2021-06-01
PANC-001
Roger Williams Medical Center
Phase 1 Withdrawn
NCT03358095 2021-05-20
Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage?
Helsinki University Central Hospital
Phase NA Withdrawn
NCT03350763 2021-05-19
Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?
Helsinki University Central Hospital
Phase NA Withdrawn
NCT03536208 2021-03-25
Biological Effect of Warfarin on Pancreatic Cancer
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT03649035 2021-03-19
Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma
Istituto Clinico Humanitas
Phase 3 Withdrawn
NCT03718650 2021-02-08
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Withdrawn
NCT03760614 2021-01-15
A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma
Abramson Cancer Center at Penn Medicine
Phase 1 Withdrawn
NCT04034745 2020-12-30
Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain
Cedars-Sinai Medical Center
Withdrawn
NCT03563352 2020-12-14
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
University of Southern California
Withdrawn
NCT02919553 2020-10-20
Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid Lesions
Loma Linda University
Phase NA Withdrawn
NCT03509298 2020-10-19
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase 2 Withdrawn
NCT02376543 2020-09-29
Comparison Study in Pancreatic Fiducial Placement
Parkview Health
Phase NA Withdrawn
NCT00226746 2020-09-18
Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer
New York Presbyterian Brooklyn Methodist Hospital
Phase 2 Withdrawn
NCT00882765 2020-07-31
Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Jonsson Comprehensive Cancer Center
Phase 2 Withdrawn
NCT01092689 2020-06-26
The Role of Meat-borne Carcinogens in Pancreatic Cancer
University of Minnesota
Phase 1 Withdrawn
NCT03891979 2020-06-26
Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma
NYU Langone Health
Phase 4 Withdrawn
NCT02713984 2020-03-19
A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer
Southwest Hospital, China
Phase 1/2 Withdrawn
NCT04058964 2020-03-13
Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT03707444 2019-11-29
A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Withdrawn